Lanutan, Charles C.
HRN: 23-58-41 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2023
AMPICILLIN 500MG (VIAL)
08/22/2023
08/29/2023
IV
410mg
Q4
PCAP C; BFC
Waiting Final Action
08/22/2023
MUPIROCIN 2%, 15G (TUBE)
08/23/2023
08/30/2023
TOPICAL
15g
BID
Dermatitis
Waiting Final Action